https://www.selleckchem.com/pr....oducts/camostat-mesi
The purpose of this study was to retrospectively evaluate the quantitative and qualitative intrapatient concordance of pulmonary nodule risk assessment by commercially available radiomics software between full-dose (FD) chest-CT and ultra-low-dose (ULD) chest CT. Between July 2013 and September 2015, 68 patients (52 men and16 women; mean age, 65.5±10.6 [SD] years; range 35-87 years) with lung nodules≥5mm and30mm who underwent the same day FD chest CT (helical acquisition; 120kV; automated tube current modulation) a
Like
Comment
Share
